Case study: carbamazepine treatment of juvenile-onset bipolar disorder.

Abstract

The literature devoted to juvenile-onset bipolar disorder has rapidly expanded in the past 5 years with an emphasis on new concepts of prevalence and comorbid conditions. In the process of enlarging the knowledge base about the phenomenology of juvenile-onset bipolar disorder, this new literature has generated considerable controversy but has provided little information about pharmacotherapy. In the following case series, carbamazepine appeared to be a safe and effective treatment for juvenile-onset bipolar disorder. Controlled studies are necessary before any definitive conclusions can be reached about the efficacy of carbamazepine in the treatment of this form of bipolar disorder.

• Authors: J L Woolston
• Journal: Journal of the American Academy of Child and Adolescent Psychiatry (J Am Acad Child Adolesc Psychiatry) Vol. 38 Issue 3 Pg. 335-8 (Mar 1999) ISSN: 0890-8567 [Print] United States
• PMID: 10087696 (Publication Type: Case Reports, Journal Article, Review)

Chemical References

• Antimanic Agents
• Carbamazepine

Topics

• Adolescent
• Antimanic Agents (administration & dosage, adverse effects)
• Bipolar Disorder (diagnosis, drug therapy, genetics)
• Carbamazepine (administration & dosage, adverse effects)
• Child
• Female
• Genetic Predisposition to Disease (genetics)
• Humans
• Male
• Treatment Outcome